These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24503276)

  • 1. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
    Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
    Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.
    Farrell K; Humphrey J; Chang T; Zhao Y; Leung YY; Kuksa PP; Patil V; Lee WP; Kuzma AB; Valladares O; Cantwell LB; Wang H; Ravi A; De Sanctis C; Han N; Christie TD; Afzal R; Kandoi S; Whitney K; Krassner MM; Ressler H; Kim S; Dangoor D; Iida MA; Casella A; Walker RH; Nirenberg MJ; Renton AE; Babrowicz B; Coppola G; Raj T; Höglinger GU; Müller U; Golbe LI; Morris HR; Hardy J; Revesz T; Warner TT; Jaunmuktane Z; Mok KY; Rademakers R; Dickson DW; Ross OA; Wang LS; Goate A; Schellenberg G; Geschwind DH; ; Crary JF; Naj A
    Nat Commun; 2024 Sep; 15(1):7880. PubMed ID: 39251599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
    Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
    Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
    Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
    Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
    Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
    Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
    Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
    Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influences on cognition in progressive supranuclear palsy.
    Gerstenecker A; Roberson ED; Schellenberg GD; Standaert DG; Shprecher DR; Kluger BM; Litvan I
    Mov Disord; 2017 Dec; 32(12):1764-1771. PubMed ID: 29076559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
    Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
    Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease.
    Liu QY; Yu JT; Miao D; Ma XY; Wang HF; Wang W; Tan L
    Neurobiol Aging; 2013 May; 34(5):1519.e13-7. PubMed ID: 23116876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
    Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
    Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
    Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
    Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
    Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
    Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy.
    Wang H; Chang TS; Dombroski BA; Cheng PL; Patil V; Valiente-Banuet L; Farrell K; Mclean C; Molina-Porcel L; Rajput A; De Deyn PP; Le Bastard N; Gearing M; Kaat LD; Van Swieten JC; Dopper E; Ghetti BF; Newell KL; Troakes C; de Yébenes JG; Rábano-Gutierrez A; Meller T; Oertel WH; Respondek G; Stamelou M; Arzberger T; Roeber S; Müller U; Hopfner F; Pastor P; Brice A; Durr A; Le Ber I; Beach TG; Serrano GE; Hazrati LN; Litvan I; Rademakers R; Ross OA; Galasko D; Boxer AL; Miller BL; Seeley WW; Van Deerlin VM; Lee EB; White CL; Morris H; de Silva R; Crary JF; Goate AM; Friedman JS; Leung YY; Coppola G; Naj AC; Wang LS; ; Dalgard C; Dickson DW; Höglinger GU; Schellenberg GD; Geschwind DH; Lee WP
    Mol Neurodegener; 2024 Aug; 19(1):61. PubMed ID: 39152475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
    de Silva R; Weiler M; Morris HR; Martin ER; Wood NW; Lees AJ
    Neurosci Lett; 2001 Oct; 311(3):145-8. PubMed ID: 11578815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
    Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases.
    Bonifati V; Joosse M; Nicholl DJ; Vanacore N; Bennett P; Rizzu P; Fabbrini G; Marconi R; Colosimo C; Locuratolo N; Stocchi F; Bonuccelli U; De Mari M; Wenning G; Vieregge P; Oostra B; Meco G; Heutink P
    Neurosci Lett; 1999 Oct; 274(1):61-5. PubMed ID: 10530520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
    Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
    JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
    Sanchez-Contreras MY; Kouri N; Cook CN; Serie DJ; Heckman MG; Finch NA; Caselli RJ; Uitti RJ; Wszolek ZK; Graff-Radford N; Petrucelli L; Wang LS; Schellenberg GD; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2018 Jul; 13(1):37. PubMed ID: 29986742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.